ResMed Inc.

ResMed Inc.

RMDยทNYSE

$186.46

+2.0%
HealthcareMedical - Devices

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

At a Glance

Live Snapshot
Market Cap$27.05B
EPS9.5500
P/E Ratio19.52
Earnings Date07/30/2026
3Y+399.0%
5Y+118.0%
10Y+220.0%
3Y-13.0%
5Y+11.0%
10Y-82.0%
3Y+372.0%
5Y+91.0%
10Y-199.0%
RMD

ResMed Inc. Cash Conversion Engine

RMD ยท NYSE
Net Income1.40B
Depreciation & Amortization235.81M
Stock-Based Compensation91.66M
Change in Working Capital16.74M
Others6.66M
Capital Expenditures-89.86M
Free Cash Flow1.66B

Cash Flow Quality Analysis

FCF Conversion Rate

118.6%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

CapEx Intensity

5.1%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

+29.2%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

+$16.74M

Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.

Cash Flow Quality Insight

Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.

ResMed Inc. Cash Flow Statement

RMD โ€ข NYSE

ResMed Inc. Cash Flow StatementJun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010Jun 2009Jun 2008Jun 2007Jun 2006
OPERATING ACTIVITIES
1.4B
1B
897.6M
779.4M
474.5M
621.7M
404.6M
315.6M
342.3M
352.4M
352.9M
345.3M
307.1M
254.9M
227M
190.1M
146.4M
110.3M
66.3M
88.2M
235.8M
216.2M
197.6M
193.8M
191.5M
181.4M
150.8M
120M
112.2M
86.8M
73.1M
73.5M
78.3M
85.9M
10.1M
61.6M
54M
59.5M
48.1M
41.6M
0.0
0.0
216K
0.0
-3.3M
39.6M
28.9M
11.6M
2M
3.6M
-25.7M
-22.6M
0.0
-12.6M
-11.2M
3.3M
-26.7M
8.9M
-18.9M
-11.9M
91.7M
80.2M
71.1M
65.3M
63.9M
57.6M
52.1M
48.4M
45.9M
46.4M
47.9M
43.5M
38.2M
30.6M
30.8M
29.7M
25.5M
0.0
0.0
0.0
6.7M
39.1M
-11.1M
20.7M
8.7M
-7K
-286K
411K
1.6M
-3M
-132K
-6.3M
-11.6M
-21.5M
49.9M
-17M
16.5M
22.2M
5.6M
22.1M
(214M)
(278.4M)
(216.9M)
(478.1M)
(221.4M)
(180.4M)
(242.9M)
(170.7M)
(92.9M)
(69M)
(48.5M)
(90.2M)
(85.7M)
(55.2M)
(85.1M)
(96.7M)
(16.9M)
(0.0)
(0.0)
(0.0)
16.7M
44.8M
-462.1M
-708.1M
1.4M
-97.9M
-177.1M
9.1M
-89.9M
61.7M
-64.8M
-42M
-9.2M
46M
-23.5M
-79.5M
23.1M
-64.9M
-69.7M
-41M
1.8B
1.4B
693.3M
351.1M
736.7M
802.3M
459.1M
505M
414.1M
547.9M
383.2M
391.3M
402.8M
383.2M
283.2M
188.2M
238.9M
137.8M
91.1M
99M
INVESTING ACTIVITIES
-89.9M
-99.5M
-134M
-156M
-116.8M
-105.9M
-77.3M
-71.5M
-71.5M
-67.8M
-71.9M
-81.2M
-71.8M
-61.1M
-75M
-61.6M
-114.2M
-75.8M
-77.6M
-102.7M
-139.2M
-133.5M
-1B
-42.8M
-39.1M
-27.9M
-951.4M
-902K
-7.3M
-1B
-28.5M
-3.9M
-5.4M
-53.3M
-22.5M
-10.7M
-2.4M
-856K
-1.9M
-10.5M
-6.4M
-22.5M
-32.2M
-20.7M
-21.8M
-46M
-47M
-29.5M
-6.5M
-16.5M
-42.7M
-12.3M
-3.3M
-6.3M
-7.9M
-4.3M
-2.3M
-6.5M
-23.6M
-4.4M
0.0
1M
3.9M
6.8M
0.0
10.6M
8.6M
-9M
3.3M
468K
937K
2.3M
2.5M
19.1M
20.9M
1.1M
240K
21.5M
2M
2M
35.5M
-15.4M
15.2M
-17.2M
19.2M
-10.6M
-8.6M
9M
3.3M
-468K
-937K
-18.4M
-9M
0.0
7.9M
17.3M
9.3M
23.8M
-4.4M
-4.2M
-200M
-269.8M
-1.2B
-229.9M
-158.5M
-179.9M
-1.1B
-101.8M
-81.9M
-1.1B
-143.1M
-95M
-78M
-101.6M
-76.5M
-58.3M
-109.3M
-37.9M
-105.4M
-119.9M
FINANCING ACTIVITIES
-225.6M
-96.9M
49.1M
47.4M
37.8M
48.2M
13.9M
-15.1M
38.3M
-74.4M
-121.5M
-168.8M
-117M
-330.3M
-68.7M
-35.9M
-43.7M
-74.9M
36.2M
34.4M
-40M
-730M
665M
122M
-522M
-94M
807.5M
-796.2M
-95M
856.3M
-1.5M
-2.2M
49.8M
144.4M
-25.2M
-38.4M
41.7M
7.4M
-10.5M
53.6M
-310.9M
-282.3M
-258.3M
-245.3M
-226.7M
-225.1M
-211.7M
-199.5M
-186.3M
-168.1M
-157.3M
-141.5M
-97.2M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-300M
-150M
(0.0)
(0.0)
(0.0)
(0.0)
-22.8M
-53.8M
(0.0)
-102.1M
-160.3M
-202.2M
-186.3M
-392.7M
-163.3M
-131.1M
-68.6M
-96.6M
-2.1M
(0.0)
-29.8M
-10.1M
-33M
-52.4M
-53.7M
-46.4M
-29M
38.2M
-19.8M
-1.2M
63.3M
15.2M
10.5M
8.7M
14.5M
13.2M
3.9M
3.8M
12.4M
9.8M
-606.3M
-1.1B
422.9M
-128.4M
-764.6M
-317.3M
580.6M
-1B
-262.9M
612.6M
-255.8M
-297.3M
-153.9M
-177.1M
-79.3M
-61.1M
1.9M
-63.8M
38.1M
97.8M
CASH FLOW SUMMARY
25.8M
-1.7M
-2.1M
-14.4M
18.5M
10.9M
-5.6M
-9.7M
21.2M
-20.6M
-172.8M
30.7M
-104.4M
-30.2M
119.2M
4.4M
-36.9M
27.1M
14.5M
438K
971.1M
10.5M
-45.8M
-21.6M
-167.9M
316M
-41.6M
-633.2M
90.5M
14.2M
-188.5M
29.7M
66.5M
74.3M
246.5M
73.1M
94.6M
63.3M
38.2M
77.4M
238.4M
227.9M
273.7M
295.3M
463.2M
147.1M
188.7M
821.9M
731.4M
717.2M
905.7M
876M
809.5M
735.3M
488.8M
415.7M
321.1M
257.8M
219.5M
142.2M
1.2B
238.4M
227.9M
273.7M
295.3M
463.2M
147.1M
188.7M
821.9M
731.4M
717.2M
905.7M
876M
809.5M
735.3M
488.8M
415.7M
321.1M
257.8M
219.5M
1.7B
1.3B
559.3M
195.1M
619.9M
696.3M
381.7M
433.6M
342.6M
480.1M
311.2M
310.1M
331M
322.1M
208.2M
126.6M
124.7M
62.1M
13.6M
-3.7M

SEC Filings

RMD - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-Q

10-Q 2026 Q1

Q1

May 01, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

April 30, 2026
April 24, 2026
2026
8-K

8-K 2026

N/A

April 30, 2026
April 30, 2026
2026
10-Q

10-Q 2025 Q4

Q4

January 30, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

January 29, 2026
January 29, 2026
2026
8-K

8-K 2025

N/A

November 20, 2025
November 19, 2025
2025
10-Q

10-Q 2025 Q3

Q3

October 31, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

October 30, 2025
October 30, 2025
2025
DEF 14A

DEF 14A 2025

N/A

October 02, 2025
June 30, 2025
2025
8-K

8-K 2025

N/A

August 18, 2025
August 15, 2025
2025
Showing 1 to 10 of 361 filings